Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder. Objectives: ...

The exponential rise in opioid prescriptions by pharmaceutical companies, despite awareness of their addictive nature, has led to a staggering toll of over 760,000 lives lost to drug overdoses since ...

Suboxone sublingual film approved to treat opioid dependence Reckitt Benckiser announced that the FDA has approved Suboxone (buprenorphine and naloxone) sublingual film for maintenance treatment of ...

Slough, UK and Richmond, VA, 20 February 2019 - Indivior PLC (LON: INDV) today announced that its U.S. affiliate, Indivior Inc., has launched an authorized generic version of SUBOXONE® (buprenorphine ...

Reckitt Benckiser Group plc Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Approval for Suboxone® (Buprenorphine and Naloxone) Sublingual Film C-III Richmond, VA (31st August 2010) - Reckitt ...

WARREN, N.J., Aug. 31 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, ...

MONTRÉAL, Sept. 28, 2021 /CNW/ - Indivior UK Ltd. is pleased to announce the Canadian launch of their new formulation of SUBOXONE (buprenorphine and naloxone soluble film). SUBOXONE Film is indicated ...

SLOUGH, England and RICHMOND, Virginia, Feb. 20, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that its U.S. affiliate, Indivior Inc., has launched an authorized generic version of ...

Two groups of sheriffs have asked Wisconsin’s Medicaid program to stop covering the film form of the addiction treatment drug Suboxone, saying the film strips are placed on artwork and in Bibles as ...

Slough, UK, 5 April 2018 - Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that its U.S. subsidiary, Indivior Inc., has filed patent lawsuits against Dr. Reddy's, Actavis, Par, ...

SUBOXONE Film can cause serious life-threatening breathing problems, overdose and death, particularly when taken by the intravenous (IV) route in combination with benzodiazepines or other medications ...